-
1
-
-
79958818528
-
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention
-
[1] Gupta, N., Limbago, B.M., Patel, J.B., Kallen, A.J., Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53 (2011), 60–67.
-
(2011)
Clin Infect Dis
, vol.53
, pp. 60-67
-
-
Gupta, N.1
Limbago, B.M.2
Patel, J.B.3
Kallen, A.J.4
-
2
-
-
84866072596
-
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy
-
[2] Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E.M., Tumietto, F., Marchese, A., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55 (2012), 943–950.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 943-950
-
-
Tumbarello, M.1
Viale, P.2
Viscoli, C.3
Trecarichi, E.M.4
Tumietto, F.5
Marchese, A.6
-
3
-
-
0037339196
-
Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates
-
[3] Smith Moland, E., Hanson, N.D., Herrera, V.L., Black, J.A., Lockhart, T.J., Hossain, A., et al. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 51 (2003), 711–714.
-
(2003)
J Antimicrob Chemother
, vol.51
, pp. 711-714
-
-
Smith Moland, E.1
Hanson, N.D.2
Herrera, V.L.3
Black, J.A.4
Lockhart, T.J.5
Hossain, A.6
-
4
-
-
85011064618
-
Antibiotic/antimicrobial resistance: biggest threats
-
CDC Atlanta (GA)
-
[4] US Centers for Disease Control and Prevention, Antibiotic/antimicrobial resistance: biggest threats. 2013, CDC, Atlanta (GA).
-
(2013)
-
-
US Centers for Disease Control and Prevention1
-
5
-
-
84953883913
-
NDM-1 during antimicrobial therapy in twin infants with pneumonia
-
NDM-1 during antimicrobial therapy in twin infants with pneumonia. Front Microbiol, 6, 2015, 1399.
-
(2015)
Front Microbiol
, vol.6
, pp. 1399
-
-
Zhu, J.1
Ding, B.2
Xu, X.3
Zhu, D.4
Yang, F.5
Zhang, H.6
-
6
-
-
33747191088
-
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase
-
e95–8
-
[6] Elliott, E., Brink, A.J., van Greune, J., Els, Z., Woodford, N., Turton, J., et al. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis, 42, 2006 e95–8.
-
(2006)
Clin Infect Dis
, vol.42
-
-
Elliott, E.1
Brink, A.J.2
van Greune, J.3
Els, Z.4
Woodford, N.5
Turton, J.6
-
7
-
-
84883312604
-
Polymyxins and doripenem combination against KPC-producing Klebsiella pneumoniae
-
[7] Lee, G.C., Burgess, D.S., Polymyxins and doripenem combination against KPC-producing Klebsiella pneumoniae. J Clin Med Res 5 (2013), 97–100.
-
(2013)
J Clin Med Res
, vol.5
, pp. 97-100
-
-
Lee, G.C.1
Burgess, D.S.2
-
8
-
-
84898983354
-
Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae
-
[8] Velkov, T., Deris, Z.Z., Huang, J.X., Azad, M.A.K., Butler, M., Sivanesan, S., et al. Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Innate Immun 20 (2014), 350–363.
-
(2014)
Innate Immun
, vol.20
, pp. 350-363
-
-
Velkov, T.1
Deris, Z.Z.2
Huang, J.X.3
Azad, M.A.K.4
Butler, M.5
Sivanesan, S.6
-
9
-
-
77953705195
-
Effectiveness and safety of colistin: prospective comparative cohort study
-
[9] Paul, M., Bishara, J., Levcovich, A., Chowers, M., Goldberg, E., Singer, P., et al. Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother 65 (2010), 1019–1027.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1019-1027
-
-
Paul, M.1
Bishara, J.2
Levcovich, A.3
Chowers, M.4
Goldberg, E.5
Singer, P.6
-
10
-
-
85006224666
-
Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal polymyxin B-based combinations
-
[10] Teo, J., Lim, T.-P., Hsu, L.-Y., Tan, T.-Y., Sasikala, S., Hon, P.-Y., et al. Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal polymyxin B-based combinations. Antimicrob Resist Infect Control 4 (2015), 1–7.
-
(2015)
Antimicrob Resist Infect Control
, vol.4
, pp. 1-7
-
-
Teo, J.1
Lim, T.-P.2
Hsu, L.-Y.3
Tan, T.-Y.4
Sasikala, S.5
Hon, P.-Y.6
-
11
-
-
0024459602
-
Antibacterial activity of meropenem against Gram-negative bacteria with a permeability defect and against staphylococci
-
[11] Kitzis, M.D., Acar, J.F., Gutmann, L., Antibacterial activity of meropenem against Gram-negative bacteria with a permeability defect and against staphylococci. J Antimicrob Chemother 24:Suppl. A (1989), 125–132.
-
(1989)
J Antimicrob Chemother
, vol.24
, pp. 125-132
-
-
Kitzis, M.D.1
Acar, J.F.2
Gutmann, L.3
-
12
-
-
84938382440
-
A space–time model for carbapenemase-producing Klebsiella pneumoniae (KPC) cluster quantification in a high-complexity hospital
-
[12] Abboud, C.S., Monteiro, J., Franca, J.I., Pignatari, A.C., De Souza, E.E., Camargo, E.C., et al. A space–time model for carbapenemase-producing Klebsiella pneumoniae (KPC) cluster quantification in a high-complexity hospital. Epidemiol Infect 143 (2015), 2648–2652.
-
(2015)
Epidemiol Infect
, vol.143
, pp. 2648-2652
-
-
Abboud, C.S.1
Monteiro, J.2
Franca, J.I.3
Pignatari, A.C.4
De Souza, E.E.5
Camargo, E.C.6
-
13
-
-
84858667238
-
Rapid detection of carbapenemase genes by multiplex real-time PCR
-
[13] Monteiro, J., Widen, R.H., Pignatari, A.C., Kubasek, C., Silbert, S., Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67 (2012), 906–909.
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 906-909
-
-
Monteiro, J.1
Widen, R.H.2
Pignatari, A.C.3
Kubasek, C.4
Silbert, S.5
-
14
-
-
84926489004
-
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
-
[14] Poirel, L., Jayol, A., Bontron, S., Villegas, M.-V., Ozdamar, M., Türkoglu, S., et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70 (2015), 75–80.
-
(2015)
J Antimicrob Chemother
, vol.70
, pp. 75-80
-
-
Poirel, L.1
Jayol, A.2
Bontron, S.3
Villegas, M.-V.4
Ozdamar, M.5
Türkoglu, S.6
-
15
-
-
84891742685
-
Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement
-
Document M100-S23. Wayne (PA): CLSI
-
[15] Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23. Wayne (PA): CLSI, 2013.
-
(2013)
-
-
Clinical and Laboratory Standards Institute1
-
16
-
-
84979714204
-
Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0
-
Available from [Accessed 7 December 2016]
-
[16] European Committee on Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. Available from http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pdf, 2016 [Accessed 7 December 2016].
-
(2016)
-
-
European Committee on Antimicrobial Susceptibility Testing1
-
17
-
-
54249107903
-
Pharmacokinetics of intravenous polymyxin B in critically ill patients
-
[17] Zavascki, A.P., Goldani, L.Z., Cao, G., Superti, S.V., Lutz, L., Barth, A.L., et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis 47 (2008), 1298–1304.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1298-1304
-
-
Zavascki, A.P.1
Goldani, L.Z.2
Cao, G.3
Superti, S.V.4
Lutz, L.5
Barth, A.L.6
-
18
-
-
84880939299
-
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens
-
[18] Sandri, A.M., Landersdorfer, C.B., Jacob, J., Boniatti, M.M., Dalarosa, M.G., Falci, D.R., et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis 57 (2013), 524–531.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 524-531
-
-
Sandri, A.M.1
Landersdorfer, C.B.2
Jacob, J.3
Boniatti, M.M.4
Dalarosa, M.G.5
Falci, D.R.6
-
19
-
-
16244372376
-
Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection
-
[19] Jaruratanasirikul, S., Sriwiriyajan, S., Punyo, J., Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother 49 (2005), 1337–1339.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 1337-1339
-
-
Jaruratanasirikul, S.1
Sriwiriyajan, S.2
Punyo, J.3
-
21
-
-
84984850920
-
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii
-
[21] Rao, G.G., Ly, N.S., Diep, J., Forrest, A., Bulitta, J.B., Holden, P.N., et al. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii. Int J Antimicrob Agents 48 (2016), 331–336.
-
(2016)
Int J Antimicrob Agents
, vol.48
, pp. 331-336
-
-
Rao, G.G.1
Ly, N.S.2
Diep, J.3
Forrest, A.4
Bulitta, J.B.5
Holden, P.N.6
-
22
-
-
85011841148
-
Transcriptomic analysis of the activity of a novel polymyxin against Staphylococcus aureus
-
pii: e00119-16
-
[22] Zhao, J., Cheah, S.-E., Roberts, K.D., Nation, R.L., Thompson, P.E., Velkov, T., et al. Transcriptomic analysis of the activity of a novel polymyxin against Staphylococcus aureus. mSphere, 1, 2016, 10.1128/mSphere.00119-16 pii: e00119-16.
-
(2016)
mSphere
, vol.1
-
-
Zhao, J.1
Cheah, S.-E.2
Roberts, K.D.3
Nation, R.L.4
Thompson, P.E.5
Velkov, T.6
-
23
-
-
84882712084
-
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
-
[23] Munoz-Price, L.S., Poirel, L., Bonomo, R.A., Schwaber, M.J., Daikos, G.L., Cormican, M., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13 (2013), 785–796.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 785-796
-
-
Munoz-Price, L.S.1
Poirel, L.2
Bonomo, R.A.3
Schwaber, M.J.4
Daikos, G.L.5
Cormican, M.6
-
24
-
-
79953851292
-
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
-
[24] Livermore, D.M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., Woodford, N., What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 37 (2011), 415–419.
-
(2011)
Int J Antimicrob Agents
, vol.37
, pp. 415-419
-
-
Livermore, D.M.1
Warner, M.2
Mushtaq, S.3
Doumith, M.4
Zhang, J.5
Woodford, N.6
-
25
-
-
0026802197
-
Agents that increase the permeability of the outer membrane
-
[25] Vaara, M., Agents that increase the permeability of the outer membrane. Microbiol Rev 56 (1992), 395–411.
-
(1992)
Microbiol Rev
, vol.56
, pp. 395-411
-
-
Vaara, M.1
-
26
-
-
42049110124
-
Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa
-
[26] Davies, T.A., Shang, W., Bush, K., Flamm, R.K., Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother 52 (2008), 1510–1512.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 1510-1512
-
-
Davies, T.A.1
Shang, W.2
Bush, K.3
Flamm, R.K.4
-
27
-
-
84876217985
-
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design
-
[27] Landersdorfer, C.B., Ly, N.S., Xu, H., Tsuji, B.T., Bulitta, J.B., Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design. Antimicrob Agents Chemother 57 (2013), 2343–2351.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 2343-2351
-
-
Landersdorfer, C.B.1
Ly, N.S.2
Xu, H.3
Tsuji, B.T.4
Bulitta, J.B.5
-
28
-
-
84861481150
-
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
-
[28] Kubin, C.J., Ellman, T.M., Phadke, V., Haynes, L.J., Calfee, D.P., Yin, M.T., Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. J Infect 65 (2012), 80–87.
-
(2012)
J Infect
, vol.65
, pp. 80-87
-
-
Kubin, C.J.1
Ellman, T.M.2
Phadke, V.3
Haynes, L.J.4
Calfee, D.P.5
Yin, M.T.6
-
29
-
-
0030995958
-
The pharmacology of meropenem, a new carbapenem antibiotic
-
S266–75
-
[29] Craig, W.A., The pharmacology of meropenem, a new carbapenem antibiotic. Clin Infect Dis, 24(Suppl. 2), 1997 S266–75.
-
(1997)
Clin Infect Dis
, vol.24
-
-
Craig, W.A.1
-
30
-
-
84858627056
-
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens
-
[30] Qureshi, Z.A., Paterson, D.L., Potoski, B.A., Kilayko, M.C., Sandovsky, G., Sordillo, E., et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 56 (2012), 2108–2113.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 2108-2113
-
-
Qureshi, Z.A.1
Paterson, D.L.2
Potoski, B.A.3
Kilayko, M.C.4
Sandovsky, G.5
Sordillo, E.6
-
31
-
-
84978328513
-
Treatment options for carbapenem-resistant Enterobacteriaceae infections
-
ofv050
-
[31] Morrill, H.J., Pogue, J.M., Kaye, K.S., LaPlante, K.L., Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis, 2, 2015 ofv050.
-
(2015)
Open Forum Infect Dis
, vol.2
-
-
Morrill, H.J.1
Pogue, J.M.2
Kaye, K.S.3
LaPlante, K.L.4
-
32
-
-
67449090359
-
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
-
[32] Roberts, J.A., Kirkpatrick, C.M., Roberts, M.S., Robertson, T.A., Dalley, A.J., Lipman, J., Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother 64 (2009), 142–150.
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 142-150
-
-
Roberts, J.A.1
Kirkpatrick, C.M.2
Roberts, M.S.3
Robertson, T.A.4
Dalley, A.J.5
Lipman, J.6
-
33
-
-
84896940320
-
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems
-
[33] Daikos, G.L., Tsaousi, S., Tzouvelekis, L.S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58 (2014), 2322–2328.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 2322-2328
-
-
Daikos, G.L.1
Tsaousi, S.2
Tzouvelekis, L.S.3
Anyfantis, I.4
Psichogiou, M.5
Argyropoulou, A.6
-
34
-
-
84898970487
-
Probing the penetration of antimicrobial polymyxin lipopeptides into Gram-negative bacteria
-
[34] Deris, Z.Z., Swarbrick, J.D., Roberts, K.D., Azad, M.A.K., Akter, J., Horne, A.S., et al. Probing the penetration of antimicrobial polymyxin lipopeptides into Gram-negative bacteria. Bioconjug Chem 25 (2014), 750–760.
-
(2014)
Bioconjug Chem
, vol.25
, pp. 750-760
-
-
Deris, Z.Z.1
Swarbrick, J.D.2
Roberts, K.D.3
Azad, M.A.K.4
Akter, J.5
Horne, A.S.6
-
35
-
-
0014447679
-
Electron microscopic studies on mode of action of polymyxin
-
[35] Koike, M., Iida, K., Matsuo, T., Electron microscopic studies on mode of action of polymyxin. J Bacteriol 97 (1969), 448–452.
-
(1969)
J Bacteriol
, vol.97
, pp. 448-452
-
-
Koike, M.1
Iida, K.2
Matsuo, T.3
-
36
-
-
84946759595
-
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics—polymyxin B and chloramphenicol
-
[36] Abdul Rahim, N., Cheah, S.-E., Johnson, M.D., Yu, H., Sidjabat, H.E., Boyce, J., et al. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics—polymyxin B and chloramphenicol. J Antimicrob Chemother 70 (2015), 2589–2597.
-
(2015)
J Antimicrob Chemother
, vol.70
, pp. 2589-2597
-
-
Abdul Rahim, N.1
Cheah, S.-E.2
Johnson, M.D.3
Yu, H.4
Sidjabat, H.E.5
Boyce, J.6
-
37
-
-
84903158590
-
Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem–ciprofloxacin combination
-
[37] Siqueira, V.L.D., Cardoso, R.F., Caleffi-Ferracioli, K.R., de Lima Scodro, R.B., Fernandez, M.A., Fiorini, A., et al. Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem–ciprofloxacin combination. Antimicrob Agents Chemother 58 (2014), 3957–3967.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 3957-3967
-
-
Siqueira, V.L.D.1
Cardoso, R.F.2
Caleffi-Ferracioli, K.R.3
de Lima Scodro, R.B.4
Fernandez, M.A.5
Fiorini, A.6
-
38
-
-
9244224674
-
Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides
-
[38] Campos, M.A., Vargas, M.A., Regueiro, V., Llompart, C.M., Alberti, S., Bengoechea, J.A., Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72 (2004), 7107–7114.
-
(2004)
Infect Immun
, vol.72
, pp. 7107-7114
-
-
Campos, M.A.1
Vargas, M.A.2
Regueiro, V.3
Llompart, C.M.4
Alberti, S.5
Bengoechea, J.A.6
-
39
-
-
84963770499
-
Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae
-
[39] Arena, F., De Angelis, L.H., Cannatelli, A., Di Pilato, V., Amorese, M., D'Andrea, M.M., et al. Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 60 (2016), 2509–2512.
-
(2016)
Antimicrob Agents Chemother
, vol.60
, pp. 2509-2512
-
-
Arena, F.1
De Angelis, L.H.2
Cannatelli, A.3
Di Pilato, V.4
Amorese, M.5
D'Andrea, M.M.6
|